SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-065899
Filing Date
2017-03-01
Accepted
2017-03-01 16:48:56
Documents
3
Period of Report
2017-03-01
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d350622d8k.htm 8-K 31129
2 EX-3.1 d350622dex31.htm EX-3.1 10164
3 EX-3.2 d350622dex32.htm EX-3.2 84836
  Complete submission text file 0001193125-17-065899.txt   127797
Mailing Address 222 THIRD STREET CAMBRIDGE MA 02142
Business Address 222 THIRD STREET CAMBRIDGE MA 02142 781-365-2596
CoLucid Pharmaceuticals, Inc. (Filer) CIK: 0001348649 (see all company filings)

IRS No.: 203419541 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37358 | Film No.: 17654920
SIC: 2834 Pharmaceutical Preparations